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Celiac  disease  in  humans  is characterized  by small  intestinal  mucosal  injury 
and malabsorption  (1).  Disease is activated by dietary exposure  to wheat gluten 
and similar proteins in rye, triticale, barley, and possibly oats (2, 3). Wheat gluten 
is a  mixture of gliadin and glutenin  (3). It is the gliadin  fraction of wheat gluten 
that is responsible for activating disease. 
Genetic  factors  and  immune  mechanisms  appear  to  be  important  in  the 
pathogenesis  of celiac disease  (3,  4).  The  HLA serologic specificities  HLA-B8, 
-DR3 and/or  -DR7,  and  -DC3  have been reported  in  as many as 60-100%  of 
celiac disease patients  (5-11).  However, <0.2%  of individuals  with  those  HLA 
specificities develop celiac disease (10),  despite  the dietary  intake of wheat and 
other  grains,  and  disease  is  not  always  concordant  among  monozygotic  twins 
(11-14).  Based  on  those  observations,  it  has  been  postulated  (15,  16)  that 
additional  environmental  factors  may be important  in  the pathogenesis  of this 
disease. 
The  present  studies  examined  known  protein  sequences  for  amino  acid  se- 
quence  homologies  with  A-gliadin,  a  wheat  gliadin  protein  component  with  a 
molecular  mass  of 31,000  daltons  that  activates  celiac  disease  (17)  and  whose 
primary  amino acid sequence has been determined  (18).  Our search  revealed a 
region  of homology between  A-gliadin  and  the 54 kilodalton  (kD) early region 
E 1  b protein of human adenovirus type 12 (Ad 12),1 an adenovirus usually isolated 
from  tbe  human  intestinal  tract  (19,  20).  Antibody  that  reacts  with  the  Adl2 
E 1  b  protein  specifically cross-reacts  with A-gliadin,  a  119 amino acid cyanogen 
bromide peptide fragment of A-gliadin containing the region of shared sequence, 
and  a  synthetic  heptapeptide  of A-gliadin  from  within  the  region  of sequence 
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homology.  These  data  suggest  that  antigenic  determinants  produced  during 
intestinal viral infection may be important in the pathogenesis of celiac disease. 
Materials and Methods 
Proteins.  A-gliadin, purified from "Scout 66"  wheat, and three cyanogen bromide 
peptides of A-gliadin (CNI, CNII, CNIII) that span the entire molecule, were prepared 
as described before (21).  CNI contains A-gliadin residues  1-127;  CNII, residues  128- 
246; and CNIII, residues 247-266.  A synthetic peptide having A-gliadin residues 211- 
217 (i.e., FRPSQQN) was prepared by solid phase synthesis at the peptide-oligonucleotide 
synthesis facility, University of California, San Diego (22). The proline residue correspond- 
ing to position 213 was radiolabeled with ~4C. For use as an immunogen, the synthetic 
peptide was coupled to ovalbumin (OVA) or bovine serum albumin (BSA) with glutaral- 
dehyde (23).  A synthetic decapeptide of cytochrome b (i.e.,  MTPMRKINPE) unrelated 
to  the  A-gliadin  synthetic peptide  was  provided  by  Dr.  R.  Doolittle,  University of 
California, San Diego (UCSD). 
Cell Lines.  Adl2 (strain Huie) transformed baby rat kidney (BRK) and baby hamster 
kidney (BHK) cells expressing the 54-kD Adl2 Elb protein and BRK cells transformed 
by a plasmid (pBR322) containing the left-hand 17% of the Ad12 genome (BRKpI~ cells) 
were provided by Dr. W. Topp, Cold Spring Harbor Laboratories, Cold Spring Harbor, 
NY. BRKp~7 cells do not express the 54-kD Adl2 Elb protein or mRNA for that protein. 
Normal BHK cells were provided by Dr. J. Klein, UCSD. All cell lines were grown in 
monolayer cultures in complete tissue culture medium (RPMI 1640 supplemented with 2 
mM  L-glutamine,  10%  fetal calf serum,  5  X  10 -5  M  2-mercaptoethanol,  100  U/ml 
penicillin, and 100 #g/ml streptomycin. 
Antiserum.  Serum reactive with the 54-kD Adl2  Elb protein used in these studies 
were as follows:  (a) Ad12 antitumor serum from rats bearing a  tumor of pAd12RIC- 
transformed baby rat kidney cells provided by Drs. A. Zantema and A. J. Van der Eb, 
University of Leiden; (b) Ad 12 antitumor serum from hamsters bearing a tumor of Ad 12- 
transformed baby hamster kidney cells provided by Dr. W. Topp; (c) antisera to Ad12- 
transformed BRK or BHK cells prepared in our laboratory. Those sera were prepared by 
injecting rats with extracts of Ad12-transformed BRK cells and hamsters with extracts of 
Ad 12-transformed BHK cells. Initial injections were in complete Freund's adjuvant (CFA) 
(107 cells/injection), followed by four to eight weekly injections of cell lysates in incomplete 
Freund's adjuvant or saline.  Rat antisera to control BRKp~ cells and hamster antisera to 
control BHK cells were prepared using the same protocol. Rabbit antisera to adenovirus 
type 5 Elb protein were a generous gift of Dr. A.J. Berk, University of California, Los 
Angeles.  Rabbit  antisera  to  A-gliadin and  the  synthetic A-gliadin heptapeptide  were 
prepared by multiply injecting rabbits with A-gliadin or synthetic A-giiadin heptapeptide 
coupled to OVA. Initial injections in CFA were followed by biweekly injections in saline. 
Monoclonal  A-Gliadin Antibodies.  Monoclonal antibodies to  the  synthetic A-gliadin 
peptide (residues  211-217)  were prepared  by fusing spleen cells  from BALB/c mice 
immunized with the synthetic peptide coupled to OVA with the routine myeloma fusion 
line NS-1.  Hybridoma tissue culture supernatants were screened by radioimmunoassay 
(RIA)  as  described  below  for activity against  A-gliadin, CNI,  CNII,  CNIII, and  the 
synthetic A-gliadin heptapeptide. Four hybridomas secreted antibody that was positive by 
RIA against A-gliadin, CNII, and the A-gliadin peptide (residues 211-217), but did not 
react with CNI or CNIII. These hybrids were cloned by limit dilution and subsequently 
used to produce ascites in BALB/c mice. Monoclonal antibody was purified from ascites 
on DEAE Affi-gei blue columns (Bio-Rad Laboratories, Richmond, CA) (24). 
Celt Labeling and Preparation  of Cell Extracts.  Cell lines grown to -80% confluency in 
100-mm tissue culture dishes were  labeled for 5  h  at  37°C  in  2  ml  methionine-free 
Dulbecco's modified Eagle's medium supplemented with L-glutamine and 2%  dialyzed 
fetal calf serum  using 50  #Ci/ml [~SS]methionine  (sp  act, >800  Ci/mmol; Amersham 
Corp., Arlington Heights, IL). Plates were washed three times with ice-cold phosphate- 
buffered saline (PBS),  pH  7.0, after which cells were harvested and centrifuged. The 1546  POSSIBLE  ROLE  OF  ADENOVIRUS  IN  CELIAC  DISEASE 
pellet was resuspended in iysis buffer (0.02 M Tris, pH 7.6, 0.15 M NaCI, 0.005 M EDTA, 
0.5% Nonidet P-40 [NP-40]) to which phenylmethylsulfonyl fluoride (PMSF) (0.3 mg/ml 
final concentration) was added. Cell suspensions were then sonicated twice for 10 s using 
a sonifier (Branson Sonic Power Co., Danbury, CT) at a setting of 5.  Equal volumes of 
salt buffer (0.02 M Tris, pH 7.6, 0.7 M NaCI, 0.005 M EDTA, 0.5% NP-40) were added 
and the viscosity of the sonicate was lowered by forcing the solution through a 23-gauge 
needle. Cellular debris was removed by centrifugation for 20 min at 15,000 g. Superna- 
tants were immunoprecipitated as described below. 
Iramunopreeipitation.  Formalin fixed Staphylococcus aureus  strain  Cowan I  cells (Pan- 
sorbin; Calbiochem-Behring Corp., La Jolla, CA) were prepared in washing buffer (0.02 
M Tris, pH 7.6,  0.5  M NaCI, 0.005  M EDTA,  1.0%  NP-40, 5.0% sucrose). Aliquots of 
cell extracts were preadsorbed with 20 #! of normal rat serum and 150 #1 of 10% (wt/vol) 
Staph A for 15 min at room temperature, after which the bacteria were pelleted. 20 ~1 of 
antisera,  as indicated  in the  text,  was added  to the preadsorbed extracts, the immune 
reaction was incubated for 30 rain at room temperature, and then 75 #1 of 10% (wt/vol) 
Staph A  was added.  The mixture was incubated for an additional  15  min on ice, after 
which the bacteria were pelleted by centrifugation.  Pellets were washed three times in 
washing buffer and once in  Tris-EDTA buffer (0.02  M  Tris, pH 6,  0.005  M  EDTA). 
Antigen-antibody complexes were solubilized at 60°C for 10 min in sample buffer (0.08 
M  Tris,  pH  6.8,  2%  sodium  dodecyl  sulfate  [SDS]  [Bio-Rad  Laboratories],  0.4  M  2- 
mercaptoethanol, 25% glycerol). After centrifugation, samples were counted and loaded 
on SDS-polyacrylamide slab gels. 
SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE).  SDS-polyacrylamide gels were run 
according to Laemmli (25) using slab gels (1.5 mm thick ×  110 mm long). The separation 
gel contained  10%  acrylamide and  0.27%  bis N,N'-methylene bisacrylamide  (Bis). The 
stacking gel contained 3% acrylamide, 0.08% Bis. Samples were electrophoresed through 
the stacking gel at  15 mA, and through the separation gel at 30 mA (constant current) 
until the bromophenyl blue front reached the bottom of the gel. After electrophoresis, 
portions of the gel were stained with Coomassie Brilliant Blue R 0.25% and then destained 
with  40%  methanol,  10%  acetic acid.  Gels subsequently  were  impregnated with  22% 
2,5,diphenyloxazole (Mallinckrodt Chemical, Paris,  KY) in dimethylsulfoxide and dried 
on a gel dryer (SE540; Hoeffer Scientific Instrument, San Francisco, CA). Dried gels were 
exposed at  -70°C  to  flash sensitized  Kodak XRP-I  film for  1-3  d.  Molecular-weight 
protein standards were included in each experiment (Bio-Rad Laboratories). 
Immunoblotting.  Western  immunoblotting  was  done  as  described  by  others  (26). 
Briefly, proteins from SDS-polyacrylamide gels were electrophoretically transferred to 
nitrocellulose paper (BA85; Schleicher & Schuell,  Inc., Keene, NH) using 20 mM Tris, 
150  mM  glycine,  and  20%  methanol  as  buffer  at  7  V/cm  overnight  at  4°C.  The 
nitrocellulose strips were soaked in 1% rabbit gamma globulin or normal mouse serum in 
buffer (5% BSA, 10 mM Tris, pH 7.4, 0.9% NaCI, 0.2%  NP-40) at 37°C for 30 min to 
saturate  additional  protein  binding  sites  and  then  rinsed  in  the  same  buffer.  Blots 
125  subsequently  were  probed with  I-labeled affinity-purified rabbit antibody or  mouse 
monoclonal antibody (2-5 ×  105 cpm/ml) in a 20-ml vol for 90 min at room temperature 
with gentle rocking, after which they were washed in  10 mM Tris, pH 7.4, 0.9% NaCI, 
0.2% NP-40 until counts returned to background levels. After blotting dry, nitrocellulose 
strips were exposed to Kodak XRP-1 film with an enhancing screen at -70°C for several 
hours overnight. 
RIA.  Solid phase RIA was performed as described before (27) using 96-U polyvinyl 
plates (2797; Costar, Data Packaging, Cambridge, MA). Briefly, wells were sensitized for 
2 h at room temperature with 50 ~I of protein (0.1  mg/ml) and then quenched with 0.2 
ml of 1% BSA in PBS, pH 7.2.  For the assay, 50 tA of test serum in titrated dilutions or 
hybridoma supernatants was added  in triplicate to individual wells and the plates were 
allowed to incubate for 2 h at room temperature. Wells were then rinsed with PBS, pH 
7.2, after which 50 tA of suitably diluted rabbit anti-mouse, rabbit anti-rat, or rabbit anti- 
hamster sera was added and the plates were incubated for an additional 2 h. Plates were 
again rinsed with PBS, after which 50 ~1 of purified ~SI-goat anti-rabbit globulin (GARG) KAGNOFF  ET  AL.  1547 
(2-3 x  104 cpm) was added to each well. After a final 2-h incubation, plates were rinsed 
and individual wells were cut with a hot wire and counted in an automatic gamma counter. 
Affinity  Chromatography.  Synthetic  A-gliadin  peptide  (residues  211-217)  OVA  was 
coupled to cyanogen bromide-activated Sepharose 4B as described by others (28).  Anti- 
body was eluted from affinity columns with  1 M acetic acid and collected into 2 M Tris. 
Computer Analysis.  The amino acid sequence of A-gliadin was screened for identities 
with known protein structures in the UCSD data bank. The data base consisted of 1,498 
protein sequences, including  1,081  entries from the Dayhoff Atlas of Protein Sequence 
and  Structure  (29)  and  417  sequences from the  UCSD  Newatt  Atlas  (30).  The latter 
contained sequence data for 139 nonenzyme eukaryotic proteins, 66 nonenzyme prokar- 
yotic proteins, 109 enzymes, and 103 animal virus proteins. We selected a sliding segment 
approach adjusted to detect 8 or more amino acid identities over a  20-residue segment 
for the  computer search since  those  boundaries  usually exclude  95-99%  of screened 
proteins. The SOAP-7 program was used to evaluate the hydrophilicity and hydrophobic- 
ity of proteins along their amino acid sequence (31). 
Results 
Sequence Homology Between A-Gliadin and the 54-kD E l b Protein of  Ad l 2.  Using 
the sliding segment boundaries selected to screen the data base, we expected to 
retrieve between  15 and  75 proteins with  8  or more amino acid identities with 
A-gliadin  over  a  20-residue  segment.  Table  I  lists  the  11  proteins  actually 
retrieved. Homology with A-gliadin for  10 of those proteins was not considered 
significant since the amino acid identities involved mainly glutamine or proline 
and included multiple gaps within the 20-residue segment. 2 of 10 proteins had 
TABLE  I 
Proteins Retrieved  from Data Base 
Number of 
proteins re- 
Number of pro-  trieved (per-  Proteins retrieved  Data Base  teins screened 
cent of pro- 
teins retrieved) 
Newatt 
Eukaryotic proteins  139  0 (0) 
Prokaryotic proteins  66  0 (0) 
Enzymes  109  1 (0.9) 
Animal viruses  103  4 (3.9) 
Dayhoff 
Atlas of protein se- 
quence and struc- 
ture 
1,081  6 (0.5) 
Total  1,498  I 1 (0.7) 
m 
m 
Chicken sulfite oxidase, heme-binding 
domain* 
Ad 12, early region Elb protein 
Ad2, fiber protein 
Sindbis virus, capsid structural protein 
Herpes simplex, 2.7-kb frame 2 Wag- 
ner protein 
Statherin, human saliva* 
Papain, papaya 
Tobacco mosaic virus dahlemense, 
coat protein 
Collagen alpha 1 chain, rat skin 
Beta casein, bovine 
Ferredoxin,  taro 
* Tetrapeptide identity with A-gliadin; LQQY. 
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tetrapeptide identities with A-gliadin. In one protein, two of four residues, and 
in  the other,  three of four residues were glutamine and/or proline (Table I). 
The glutamine and proline identities with A-gliadin were expected since 32/100 
residues in A-gliadin are glutamine and 15/100 residues are proline (18). 
The region of homology between A-gliadin and the early region Elb protein 
of human Ad 12 (32, 33) appeared potentially important. As shown in Fig. 1, the 
region  included  8  identities  over a  span  of  12  amino  acid  residues,  had  an 
uninterrupted 5-residue identity that was not present in the other 1,498 protein 
sequences, and involved only 1 proline and glutamine residue in the Elb protein. 
Homology with Adl2 Elb occurred in domain V  of A-gliadin, a  domain that 
lacks repeating sequences with a high glutamine and proline content (18). 
Examination of the hydropathic character (31) of A-gliadin and the Ad 12 E 1  b 
protein indicated that, for both molecules, the region of homology was hydro- 
philic and  likely to  be  located on  the exterior of the molecule (Fig.  2).  The 
region of homology between A-gliadin and the Adl 2 Elb protein would not be 
predicted to have a-helix or ~-sheet conformation when analyzed by the structure 
prediction method of Chou and Fasman (34). 
Antisera to a Synthetic A-Gliadin Peptide (Residues 211-217)from within the Region 
of Sequence Homology Cross-reacts with the 54-kD Ad12 Elb Protein.  The expres- 
sion of the Adl2 Elb genes in the Adl2-transformed BRK and BHK cell lines 
was verified by immunoprecipitation of 35S-labeled  cell extracts with antitumor 
serum or antiserum to extracts of those cells. Fig.  3  shows autoradiograms of 
SDS-polyacrylamide gels used to separate the immunoprecipitated proteins. Both 
the Adl 2-transformed BRK and BHK cell lines express the 54-kD E lb protein 
(Fig. 3). The 54-kD Adl 2 Elb protein was not detected in control BRKpI7 cells 
or normal BHK cells immunoprecipitated with the same antisera and was not 
immunoprecipitated from Adl2-transformed BRK or BHK cells by normal rat 
or hamster serum or by serum from rats immunized with control BRKp~7 cells. 
Western immunoblotting documented reactivity between the 54-kD Adl2 Elb 
protein and affinity-purified rabbit (Fig.  4) or murine monoclonal antibody to 
the synthetic A-gliadin heptapeptide (residues 211-217) from within the region 
of sequence homology. 
Immunologic  Cross-reactivity Between the Adl2 EIb Protein, A-Gliadin,  and A- 
Gliadin  Peptides.  Fig.  5  shows that rat antiserum to Adl 2-transformed BRK 
cell extracts (i.e., Elb  +) cross-reacts by RIA with the synthetic A-gliadin hepta- 
peptide (residues 211-217), whereas rat antiserum to extracts of control BRKpt7 
cells (i.e., Elb-) does not. Control antisera to adenovirus type 5 Elb protein, a 
protein that is highly homologous with Ad 12 E 1  b (32, 33) but not with A-gliadin, 
also do not cross-react with the synthetic A-gliadin heptapeptide (Fig. 5). 
Anti-A-gliadin heptapeptide (residues 211-217) antibody was affinity-purified 
from antiserum to Adl2-transformed BRK cell extracts on A-gliadin heptapep- 
384  387  389  395 
A-Gliodin  ~  G  S 
206  209  211  217 
FIGURE  1.  Amino acid sequence of AdI2 Elb protein and A-gliadin beginning at residues 
384 and 206, respectively. The single-letter code is that recommended by the IUPAC (43). KAGNOFF  ET  AL.  1549 
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FIGURE 2.  Hydropathic character of A-gliadin and Adl2  Elb protein.  The figure depicts 
the hydrophilic and hydrophobic character of A-gliadin over the segment spanning residues 
198-232 (top) and ofAdl 2 Elb protein over the segment spanning residues 375-410 (bottom). 
Regions below the solid line are likely to be on the exterior of the molecule. 
tide  (residues  211-217)/OVA/Sepharose  4B  columns and  tested  by  RIA  for 
binding to A-gliadin and A-gliadin peptides. As shown in Fig. 6, affinity-purified 
antibody reacted with synthetic A-gliadin peptide (residues 211-217),  intact A- 
gliadin, and the CNII  pepfide of A-gliadin (residues  128-246)  containing the 
region of shared sequepqce between A-gliadin and the Ad 12 E 1  b  protein. The 
same affinity-purified antibody did not react with CNI peptide (A-gliadin residues 
1-127), CNIII peptide (A-gliadin residues 247-268), or a control protein (BSA). 
Further studies demonstrated that rat  or hamster antiserum to Adl2-trans- 
formed BRK or BHK cell extracts cross-reacts with A-gliadin (Fig. 7). In contrast, 
control rat and hamster serum, antisera to control BRKp17 cell extracts (Elb-), 
and antisera to control BHK cell extracts (Elb-) do not cross-react with A-gliadin 
(Fig.  7).  Finally, as shown in  Fig.  8,  rabbit antisera  to the synthetic A-gliadin 
peptide (residues 211-217)  reacts with proteins immunoprecipitated from the 
Adl 2-transformed BRK cell line and binding is specifically inhibited by free A- 
gliadin heptapeptide (Fig. 8). 
Discussion 
These studies demonstrate a region of amino acid sequence homology between 
the  Adl2  E lb  protein  and  A-gliadin,  an  aipha-gliadin  component known  to 1550  POSSIBLE  ROLE  OF  ADENOVIRUS  IN  CELIAC  DISEASE 
FIGURE 3.  [sSS]Methionine-labeled  proteins  were  immunoprecipitated  from  Adl2-trans- 
formed BRK or BHK cells as described in Materials and Methods. Immunoprecipitates were 
run on 10% SDS-polyacrylamide gels. Autoradiograms were prepared as described in Materials 
and Methods. Arrow indicates the position of the 54-kD Elb protein. (A) Extracts of Adl2- 
transformed BRK cells immunoprecipitated with Adl2  antitumor sera from rats bearing a 
tumor  of pAdl2RIC-transformed  BRK  cells;  (B)  extracts of Adl2-transformed  BRK  cells 
immunoprecipitated with rat antiserum to BRK cell extracts; (C) extracts of Ad 12-transformed 
BHK cells immunoprecipitated with rat antiserum to BRK cell extracts.  Not shown: the 54- 
Kd E1 b protein was not present in control BRKpI7 cells or nontransformed BHK cells and was 
not precipitated from Ad 12-transformed BRK or BHK cells by normal rat or hamster serum 
or by serum from rats immunized with control BRKp~7 cell extracts. 
FIGURE 4.  Western immunoblotting analysis of Adl2 Elb protein from Adl2-transformed 
BRK and BHK cells. Immunoprecipitates of Adl 2-transformed BRK and BHK cells separated 
on SDS-polyacrylamide gels were electrophoretically transferred to nitrocellulose paper and 
then probed with 125I-labeled  affinity-purified rabbit antibody to synthetic A-gliadin peptide 
(residues 211-217). Antibody to the A-gliadin peptide reacted only with the 54-kD Ad 12 E 1  b 
protein (arrow). KAGNOFF  ET  AL.  1551 
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FIGURE 5.  Antiserum to Adl 2-transformed BRK cells cross-reacts  with synthetic A-gliadin 
heptapeptide (residues 211-217).  RIA in which wells of microtiter plates were sensitized with 
synthetic A-gliadin heptapeptide (residues 211-217) coupled to BSA as described in Materials 
and Methods. As shown, rat antiserum to Ad 12-transformed BRK cells (E 1  b +) (0) reacts with 
synthetic A-gliadin heptapeptide (residues 211-217),  whereas rat antiserum to control BRKp17 
cells (Elb-) (A) does not.  Two different rabbit antisera  to adenovirus type 5  Elb protein, a 
protein that is highly homologous with Adl2 Elb but not with A-gliadin, do not react with 
the A-gliadin heptapeptide (C); I-1). Control prebleed rat serum, normal rat serum, and normal 
rabbit serum resulted in binding of 100-200  cpm at serum dilutions of l:10O0.  Counts per 
minute obtained in control w~lls sensitized with BSA have been subtracted as background. 
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FIGURE 6.  Anti-A-gliadin  heptapeptide  (residues  211-217) antibody  affinity-purified  from 
antiserum to  Adl2-transformed  BRK cell extracts  cross-reacts  with A-gliadin and A-gliadin 
peptides that share homology with the Ad 12 E 1  b protein.  Antibody to the synthetic A-gliadin 
peptide (residues  211-217) was affinity-purified  from antiserum  to Ad 12-transformed  BRK 
cells and tested  by RIA for binding  to A-gliadin and A-gliadin  peptides.  As shown, affinity- 
purified antibody reacts with A-gliadin  heptapeptide  (residues 211-217) (Q), the CNII frag- 
ment of A-gliadin (residues  128-246) (I), and intact A-gliadin (residues  1-266) (&), but not 
with the CNII] fragment (residues 247-266) (O) or the CNI fragment (residues 1-127) (I-I)  of 
A-gliadin or with BSA (A). 
activate  human  celiac  disease  (17).  Adl2  is a  human  adenovirus  that  is  usually 
isolated  from  the  intestinal  tract and can be detected  as early as the  first  1-2  yr 
of life  (19,  20).  Adl2  has  not  been  implicated  previously  as a  cause  of human 
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FIGURE 7.  Antisera to Adl2-transformed BRK and BHK cell extracts cross-reacts with A- 
gliadin. RIA in which rat antiserum  to Adl2-transformed  BRK (Elb  +) celt extracts (O)  or 
hamster antiserum to Ad 12-transformed BHK (E 1  b +) (O) cell extracts were added to wells of 
microtiter  plates  sensitized  with  ~-gliadin.  Binding  with  prebleed  rat  or  hamster  serum, 
antiserum to BRKpI¢ cell extracts (E 1  b-), and antiserum to nontransformed BHK cell extracts 
(Elb-) was <500 cpm at serum dilutions of 1:1000. 
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FIGURE 8.  Rabbit antisera  to synthetic  A-gliadin peptide (residues  21 I-217)  (O) binds to 
immunoprecipitates of Adl 2-transformed  BRK cells and binding is specifically !nhibited by 
free A-gliadin heptapeptide. Wells of microtiter plates were sensitized with proteins immuno- 
precipitated from Ad 12-transformed BHK cells as outlined in Methods and Materials. Binding 
of rabbit  anti-A-gliadin heptapeptide  antibody  was  specifically inhibited  by  free  A-gliadin 
peptide (residues 211-217)  (1  ~M/ml) (11), but not by an unrelated peptide (cytochrome b 
sequence MTPMRKINPE) (not shown).  Binding of hyperimmune rabbit serum to unrelated 
antigens (e.g., murine IgG2a, sonicates of the parasite Giardia  larablia, sheep erythrocytes) was 
<500 cpm at serum dilutions of 1:3000. 
The region of homology between A-gliadin and the 54-kD Adl2 Elb protein 
spanned  12  amino  acids  and  included  8  residue  identities  and  an  identical 
pentapeptide. A-gliadin has 32 glutamines and  15 prolines per 100 amino acid 
residues (18).  However, the region of homology occurred in  domain V  of A- 
gliadin,  a  domain  that  lacks  repeating  sequences with  a  high  glutamine and 
proline content (18).  Further, the region included only a single glutamine and 
proline residue in  the Adl2  Elb  protein.  Homology between the Adl2  Elb 
protein and A-gliadin is probably due to chance since these proteins are unrelated 
functionally and are not likely to share a common ancestry. 
Enzyme digestion studies (3) have suggested that the essential peptide in gliadin 
that activates celiac disease may contain as few as  10 amino acids, although the 
frequency with which that sequence occurs in gliadin is not known. The high KAGNOFF ET  AL.  1553 
glutamine and proline content of wheat storage proteins alone does not seem 
sufficient to activate celiac disease in that wheat glutenins are rich in proline and 
glutamine,  but  do  not  appear  to  activate disease (3).  Omega-gliadins have a 
higher content of glutamine and proline than A-gliadin (3) (i.e., 45-56 glutamines 
and 20-30 prolines per 100 residues), but in a recent in vivo study (35), they did 
not appear to activate celiac disease. Among the 10 other proteins that had 8 or 
more amino acid identities with A-gliadin over a  20-residue segment, identities 
occurred mainly  in  regions  rich  in  glutamine or  proline.  Further,  identities 
between  A-gliadin  and  those  proteins  included  many  gaps,  and  at  most  an 
identical tri- or tetrapeptide. 
The region of homology was hydrophilic in both A-gliadin and the Ad 12 E 1  b 
protein, and thus was more likely to be on the exterior of those proteins (31). 
Further, antisera reactive with the 54-kD Adl2 Elb protein specifically cross- 
reacted with A-gliadin, the 119 amino acid CNII A-gliadin peptide that contains 
the region of shared sequence, and the synthetic heptapeptide of A-gliadin from 
within the region of homology. The same antisera did not react with CNI or 
CNIII  fragments of A-gliadin  that  are  not  homologous with  the  Adl2  Elb 
protein or with irrelevant control proteins. Serum from normal rats or hamsters 
and antiserum to extracts of control BRKp~7 cells or normal hamster cells that 
lack the Ad 12 E 1  b protein did not cross-react with A-gliadin or the synthetic A- 
gliadin heptapeptide. Although E 1  b from Ad5 is highly homologous with Ad 12 
Elb  (32,  33),  it  does not share a  region of homology with  A-gliadin and, as 
predicted, antisera to Ad5 Elb do not cross-react with A-gliadin or its peptides. 
Taken together, these studies indicate that antibody to the native 54-kD Adl 2 
E lb  protein  specifically  cross-reacts  with  A-gliadin  in  the  region  of shared 
sequence. Conversely, affinity-purified rabbit antibody to intact A-gliadin was 
shown to cross-react with CNII  peptide, the synthetic A-gliadin heptapeptide, 
and E lb containing immunoprecipitates of Adl 2  transformed BRK cells (data 
not shown). 
Adl 2 is a double-stranded DNA virus and is known to transform mammalian 
cell lines (19). Further, cells transformed by Adl 2 induce tumors in rodents at a 
high  frequency within a  relatively short  time period  (36).  The  transforming 
activity of Ad 12 has been assigned to the left-hand 11% of the viral genome (i.e., 
early region I) (37), which contains two transcriptional units, Ela and Elb in a 
3.9-kb DNA segment (38, 39). Those units are the first to be expressed during 
lytic infection of cells.  The Elb genomic region codes for the 54-kD protein 
described in this study, as well as a  19-kD polypeptide (32,  33).  Recently, the 
oncogenic potential of Ad 12 has been associated with a decreased expression of 
class  1 major histocompatibility complex antigens on the surface of infected cells, 
which may render those cells less susceptible to elimination by T  cell killing (40, 
41). In this regard, we note also that the risk of malignant neoplasms, particularly 
lymphoma and  carcinoma of the  small  intestine,  is  significantly increased  in 
patients with celiac disease (42). 
Genetic, environmental, and immune factors all appear to have an important 
role in the pathogenesis of celiac disease. The basis for the association between 
celiac disease and specific HLA specificities is not known. Depending on geo- 
graphic origin, HLA-B8, -DR3 and/or -DR7, and -DC3 occur in as many as 60- 1554  POSSIBLE ROLE OF ADENOVIRUS IN  CELIAC DISEASE 
100% of these patients (5-11). Although the same HLA specificities are present 
in 20-30% of the normal population, <0.2% of those individuals develop celiac 
disease, despite the ingestion of wheat and other grains known to activate disease. 
Moreover, disease is not always concordant among monozygotic twins (11-14). 
The present  studies  suggest  that  the  frequent occurrence of specific  HLA 
hapiotypes in  celiac disease may reflect the presence of genes associated with 
those haplotypes that govern the host's immune response to specific viral infec- 
tion. Encounter of the immune system with a protein produced during intestinal 
viral infection may be important in the pathogenesis of celiac disease, because of 
chance immunologic cross-reactivity between the viral protein and dietary glia- 
din.  After the ingestion  of gliadin,  gliadin peptides associated with  intestinal 
mucosal structures (4) might serve as the target of immune-mediated injury. 
Summary 
Celiac disease in humans is activated by the dietary ingestion of wheat, rye, 
triticale, barley, and possibly oats. Gliadins in wheat and similar proteins in the 
other grains are known to activate disease in susceptible individuals. There is a 
striking association between celiac disease and HLA-B8, -DR3 and/or -DR7, and 
-DC3. Nonetheless, <0.2%  of individuals with those serologic HLA specificities 
develop celiac disease and disease is not always concordant among monozygotic 
twins.  We propose that additional environmental factors may be important in 
the pathogenesis of celiac disease. To investigate that possibility, we examined a 
data bank of protein sequences for other proteins that might share amino acid 
sequence  homologies  with  A-gliadin,  an  alpha-gliadin  component  known  to 
activate celiac disease and whose complete primary amino acid sequence is known. 
These studies demonstrate that A-gliadin shares a region of amino acid sequence 
homology with the 54-kD Elb protein of human adenovirus type 12 (Adl 2), an 
adenovirus usually isolated from the intestinal tract. The region spans 12 amino 
acid residues, includes 8 residue identities and an identical pentapeptide, and is 
hydrophilic in both proteins. Antibody reactive with the 54-kD Ad 12 E 1  b protein 
cross-reacts with A-gliadin, a  119 amino acid cyanogen bromide peptide of A- 
gliadin that spans the region of homology and a  synthetic heptapeptide of A- 
gliadin from within the region of homology. We suggest that an encounter of 
the immune system with antigenic determinants produced during intestinal viral 
infection may be important in the pathogenesis of celiac disease. 
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